DURECT CorpNASDAQ:DRRX
- LAST PRICE1.7100
- TODAY'S CHANGE (%)0.3600 (26.6667%)
- Bid / Lots1.7300/ 5
- Ask / Lots1.7600/ 8
- Open / Previous Close1.3400 / 1.3500
- Day Range
- 52 Week Range
- Volume565,903
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | DRRX |
|---|---|---|
| 09:32 ET | 413 | 1.34 |
| 09:34 ET | 160 | 1.331 |
| 09:38 ET | 100 | 1.39 |
| 09:41 ET | 134 | 1.36 |
| 09:48 ET | 200 | 1.36 |
| 09:54 ET | 100 | 1.38 |
| 09:59 ET | 10100 | 1.395 |
| 10:01 ET | 1100 | 1.39 |
| 10:03 ET | 100 | 1.39 |
| 10:06 ET | 100 | 1.39 |
| 10:08 ET | 100 | 1.39 |
| 10:10 ET | 200 | 1.4 |
| 10:12 ET | 100 | 1.4 |
| 10:14 ET | 1782 | 1.4 |
| 10:15 ET | 100 | 1.4 |
| 10:17 ET | 100 | 1.4 |
| 10:19 ET | 100 | 1.42 |
| 10:28 ET | 100 | 1.42 |
| 10:30 ET | 800 | 1.42 |
| 10:39 ET | 9160 | 1.4398 |
| 10:44 ET | 1306 | 1.4383 |
| 10:46 ET | 770 | 1.44 |
| 10:50 ET | 1313 | 1.44 |
| 10:53 ET | 567 | 1.45 |
| 10:55 ET | 1848 | 1.47 |
| 10:57 ET | 19615 | 1.44 |
| 11:02 ET | 100 | 1.46 |
| 11:04 ET | 200 | 1.4641 |
| 11:08 ET | 100 | 1.4699 |
| 11:09 ET | 100 | 1.4699 |
| 11:13 ET | 8391 | 1.47 |
| 11:15 ET | 2500 | 1.4724 |
| 11:18 ET | 270 | 1.46 |
| 11:20 ET | 400 | 1.48 |
| 11:27 ET | 11322 | 1.4801 |
| 11:29 ET | 800 | 1.51 |
| 11:31 ET | 600 | 1.51 |
| 11:33 ET | 1000 | 1.505 |
| 11:36 ET | 501 | 1.5 |
| 11:40 ET | 300 | 1.515 |
| 11:44 ET | 151 | 1.52 |
| 11:45 ET | 3274 | 1.525 |
| 11:51 ET | 141 | 1.5389 |
| 11:54 ET | 12137 | 1.5105 |
| 11:56 ET | 2421 | 1.5097 |
| 11:58 ET | 22253 | 1.53 |
| 12:00 ET | 10350 | 1.5 |
| 12:02 ET | 2193 | 1.4999 |
| 12:05 ET | 666 | 1.4999 |
| 12:07 ET | 3748 | 1.4901 |
| 12:09 ET | 6650 | 1.49 |
| 12:18 ET | 200 | 1.48 |
| 12:20 ET | 689 | 1.48 |
| 12:21 ET | 100 | 1.485 |
| 12:27 ET | 2250 | 1.4801 |
| 12:34 ET | 170 | 1.4984 |
| 12:36 ET | 111 | 1.4995 |
| 12:39 ET | 6700 | 1.5 |
| 12:45 ET | 3000 | 1.5399 |
| 12:50 ET | 8968 | 1.55 |
| 12:52 ET | 2000 | 1.5507 |
| 12:56 ET | 500 | 1.5666 |
| 12:59 ET | 370 | 1.56 |
| 01:01 ET | 110 | 1.57 |
| 01:03 ET | 132 | 1.57 |
| 01:06 ET | 2500 | 1.5799 |
| 01:08 ET | 6000 | 1.62 |
| 01:10 ET | 1700 | 1.604 |
| 01:12 ET | 100 | 1.58 |
| 01:14 ET | 1637 | 1.581 |
| 01:15 ET | 10158 | 1.615 |
| 01:17 ET | 682 | 1.62 |
| 01:19 ET | 6952 | 1.63 |
| 01:21 ET | 25857 | 1.61 |
| 01:24 ET | 18626 | 1.5948 |
| 01:26 ET | 300 | 1.61 |
| 01:28 ET | 11357 | 1.5824 |
| 01:30 ET | 200 | 1.59 |
| 01:32 ET | 7900 | 1.59 |
| 01:33 ET | 300 | 1.57 |
| 01:35 ET | 600 | 1.57 |
| 01:37 ET | 3498 | 1.5799 |
| 01:39 ET | 1000 | 1.575 |
| 01:42 ET | 200 | 1.59 |
| 01:46 ET | 400 | 1.6 |
| 01:48 ET | 3500 | 1.6 |
| 01:50 ET | 3400 | 1.61 |
| 01:51 ET | 2100 | 1.61 |
| 01:53 ET | 4200 | 1.62 |
| 01:55 ET | 6816 | 1.6499 |
| 02:00 ET | 7515 | 1.6 |
| 02:02 ET | 100 | 1.63 |
| 02:04 ET | 2100 | 1.6492 |
| 02:08 ET | 300 | 1.65 |
| 02:09 ET | 1525 | 1.65 |
| 02:11 ET | 3691 | 1.63 |
| 02:15 ET | 500 | 1.655 |
| 02:18 ET | 275 | 1.6766 |
| 02:20 ET | 381 | 1.67 |
| 02:22 ET | 110 | 1.64 |
| 02:24 ET | 100 | 1.68 |
| 02:26 ET | 14940 | 1.62 |
| 02:27 ET | 3063 | 1.63 |
| 02:29 ET | 400 | 1.65 |
| 02:31 ET | 2337 | 1.6499 |
| 02:33 ET | 837 | 1.6406 |
| 02:38 ET | 5901 | 1.6756 |
| 02:40 ET | 999 | 1.7 |
| 02:42 ET | 550 | 1.695 |
| 02:44 ET | 21323 | 1.6901 |
| 02:45 ET | 3461 | 1.71 |
| 02:47 ET | 900 | 1.72 |
| 02:49 ET | 1340 | 1.71 |
| 02:51 ET | 3200 | 1.702 |
| 02:54 ET | 5548 | 1.6901 |
| 02:56 ET | 518 | 1.6901 |
| 02:58 ET | 1196 | 1.69 |
| 03:00 ET | 500 | 1.7 |
| 03:02 ET | 400 | 1.7 |
| 03:03 ET | 700 | 1.7 |
| 03:05 ET | 4105 | 1.6999 |
| 03:09 ET | 786 | 1.69 |
| 03:12 ET | 4300 | 1.69 |
| 03:14 ET | 851 | 1.7 |
| 03:16 ET | 2789 | 1.7 |
| 03:18 ET | 1173 | 1.67 |
| 03:20 ET | 989 | 1.66 |
| 03:21 ET | 12446 | 1.69 |
| 03:23 ET | 1080 | 1.69 |
| 03:25 ET | 780 | 1.67 |
| 03:27 ET | 800 | 1.69 |
| 03:30 ET | 1573 | 1.6899 |
| 03:32 ET | 2445 | 1.67 |
| 03:34 ET | 6312 | 1.7 |
| 03:36 ET | 2600 | 1.75 |
| 03:38 ET | 7066 | 1.77 |
| 03:39 ET | 8450 | 1.76 |
| 03:41 ET | 9481 | 1.755 |
| 03:43 ET | 6923 | 1.76 |
| 03:45 ET | 17927 | 1.77 |
| 03:48 ET | 7755 | 1.75 |
| 03:50 ET | 5065 | 1.75 |
| 03:52 ET | 3130 | 1.74 |
| 03:54 ET | 6706 | 1.69 |
| 03:56 ET | 745 | 1.69 |
| 03:57 ET | 15304 | 1.685 |
| 03:59 ET | 10105 | 1.71 |
May 21, 2024
DURECT Corporation Receives FDA Breakthrough Therapy Designation for Larsucosterol in Alcohol-Associated Hepatitis, from 8:00AM ET on Tuesday May 21, 2024 by Dow Jones
8:00AM ET on Tuesday May 21, 2024 by Dow Jones
May 13, 2024
*DJ Durect 1Q Loss/Shr 25c >DRRX, from 4:05PM ET on Monday May 13, 2024 by Dow Jones
4:05PM ET on Monday May 13, 2024 by Dow JonesDURECT Corporation Reports First Quarter 2024 Financial Results and Business Update, from 4:05PM ET on Monday May 13, 2024 by Dow Jones
4:05PM ET on Monday May 13, 2024 by Dow Jones
May 7, 2024
DURECT Corporation to Announce First Quarter 2024 Financial Results and Provide a Business Update, from 4:30PM ET on Tuesday May 07, 2024 by Dow Jones
4:30PM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
DURECT Corp | 53.1M | -2.0x | --- |
Kezar Life Sciences Inc | 50.5M | -0.5x | --- |
Atara Biotherapeutics Inc | 67.5M | -0.3x | --- |
Curis Inc | 61.1M | -1.2x | --- |
LAVA Therapeutics NV | 59.4M | -2.1x | --- |
Kronos Bio Inc | 47.5M | -0.4x | --- |
Company Information
DURECT Corporation is a late-stage biopharmaceutical company pioneering the development of epigenetic therapies that target dysregulated deoxyribonucleic acid (DNA) methylation to transform the treatment of serious and life-threatening conditions, including acute organ injury and cancer. Larsucosterol is in clinical development for the potential treatment of alcohol-associated hepatitis, for which United States Food and Drug Administration (FDA) has granted a Fast Track Designation; metabolic dysfunction-associated steatohepatitis is also being explored. Its commercial pharmaceutical products include POSIMIR (bupivacaine solution), PERSERIS (schizophrenia) and Methydur Sustained Release Capsules (ADHD). POSIMIR (bupivacaine solution) for infiltration use, a non-opioid analgesic utilizing the SABER platform technology, is FDA-approved. Its ALZET product line consists of miniature, implantable osmotic pumps and accessories used for research in mice, rats and other laboratory animals.
Contact Information
- Headquarters
- 10240 Bubb RoadCUPERTINO, CA, United States 95014
- Phone
- 408-777-1417
- Fax
- 408-777-3577
Executives
- Independent Chairman of the Board
- Gail Maderis
- President, Chief Executive Officer, Director
- James Brown
- Chief Financial Officer, Company Secretary
- Timothy Papp
- Senior Vice President - Operations and Corporate Quality Assurance
- Judy Joice
- Chief Medical Officer
- Norman Sussman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $53.1M |
|---|---|
Revenue (TTM) | $8.3M |
Shares Outstanding | 31.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.12 |
EPS | $-0.87 |
Book Value | $0.49 |
P/E Ratio | -2.0x |
Price/Sales (TTM) | 6.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -379.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
